Aerovate Therapeutics Struggles Amid Market Volatility in Biotech Sector
Aerovate Therapeutics Inc. is navigating market fluctuations and challenges as a biotech company, but remains committed to developing innovative treatments for cardiopulmonary diseases.
2 minutes to read